BIOXYTRAN, INC (BIXT)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312021-Mar-312020-Dec-312020-Sep-302020-Jun-302020-Mar-312019-Dec-312019-Sep-302019-Jun-302019-Mar-312018-Dec-312018-Sep-302018-Jun-302018-Mar-312017-Dec-312017-Sep-302017-Jun-302017-Mar-312016-Dec-312016-Sep-302016-Jun-302016-Mar-312015-Dec-312015-Sep-302015-Jun-302015-Mar-312014-Dec-312014-Sep-302014-Jun-30
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016Q2-FY2016Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q4-FY2014Q3-FY2014Q2-FY2014
Total Assets658,552$156,294$147,501$136,052$138,694$159,008$128,553$125,540$139,382$189,043$370,936$385,303$326,403$633$4,246$43,891$219,628$33,226$45,279$118,931$36,411$2,831$686,207$691,704$110$76,764$21,565$29,226$51,671$81,829$56,571$50,190$55,816$96,861$119,138$97,615$113,283$223,837$248,593$
Total Current Assets513,465$14,499$3,144$4,348$5,154$34,672$13,522$10,024$26,086$295,401$366,350$316,403$633$4,246$43,891$219,628$33,226$45,279$118,931$36,411$2,831$12,762$13,896$110$65,229$5,653$8,882$26,964$52,655$22,710$9,448$3,481$33,389$41,118$5,047$6,168$102,174$112,382$
Cash and Cash Equivalents23,448$3,050$11,092$18,773$22,710$9,448$3,481$11,647$776$2,730$6,168$15,626$7,170$
Receivables
Other Current Assets
Assets Held for Sale in Short Term
Total Noncurrent Assets145,087$141,795$144,357$131,704$133,540$124,336$115,031$115,516$113,296$189,043$75,535$18,953$10,000$0$0$0$0$0$0$0$0$0$673,445$677,808$0$11,535$15,912$20,344$24,707$29,174$33,861$40,742$52,335$63,472$78,020$92,568$107,115$121,663$136,211$
Goodwill
Other Intangible Assets145,087$141,795$144,357$131,704$133,540$124,336$115,031$115,516$113,296$75,535$18,953$10,000$
Physical Assets673,445$677,808$682,171$11,535$15,912$20,344$24,707$29,174$33,861$40,742$52,335$63,472$78,020$92,568$107,115$121,663$136,211$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities3,249,894$3,060,937$2,782,771$2,844,089$1,930,642$1,243,578$1,228,509$1,115,901$3,244,238$2,332,959$3,667,911$2,878,322$2,267,659$2,093,163$1,903,943$1,881,041$1,018,915$1,213,866$702,187$773,821$261,725$52,609$150,109$178,927$1,419$421,714$415,398$384,407$342,266$342,703$268,455$276,450$251,035$177,126$405,652$358,124$334,735$300,709$259,200$
Total Current Liabilities3,249,894$3,060,937$2,782,771$2,844,089$1,930,642$1,243,578$1,228,509$1,115,901$3,244,238$3,667,911$2,878,322$2,267,659$2,093,163$1,903,943$1,881,041$1,018,915$1,213,866$702,187$773,821$261,725$1,419$421,714$415,398$384,407$342,266$342,703$268,455$276,450$251,035$177,126$405,652$358,124$334,735$300,709$
Accounts Payable8,115$
Short Term Debt
Short Term Capital Lease Obligations
Other Current Liabilities
Total Noncurrent Liabilities0$0$0$0$0$0$0$0$0$2,332,959$0$0$0$0$0$0$0$0$0$0$0$52,609$150,109$178,927$0$0$0$0$0$0$0$0$0$0$0$0$0$0$259,200$
Long Term Debt
Long Term Capital Lease Obligations
Other Noncurrent Liabilities
Total Equity(2,591,342$)(2,904,643$)(2,635,270$)(2,708,037$)(1,791,948$)(1,084,572$)(1,099,957$)(990,424$)(3,104,857$)(2,143,916$)(2,662,182$)(4,060,523$)(3,296,975$)(3,158,207$)(1,309,542$)(1,053,165$)(2,092,530$)(1,899,697$)(1,837,150$)(799,287$)(1,180,640$)(656,908$)(654,890$)(225,314$)(49,778$)(1,979$)(1,309$)(1,309$)(344,950$)(393,833$)(355,181$)(290,595$)(260,874$)(211,884$)(226,260$)(195,219$)(80,265$)(286,514$)(260,509$)(221,452$)(76,872$)(10,607$)
Equity to Minority(694,210$)(694,210$)(680,886$)(659,063$)(590,628$)1,183,477$888,091$
Equity to Common Shareholders(2,591,342$)(2,904,643$)(2,635,270$)(2,708,037$)(1,791,948$)(1,084,572$)(1,099,957$)(990,424$)(3,104,857$)(2,143,916$)(2,662,182$)(4,060,523$)(3,296,975$)(3,158,207$)(2,493,019$)(1,941,256$)(2,092,530$)(1,899,697$)(1,837,150$)(799,287$)(1,180,640$)(656,908$)(654,890$)(225,314$)(49,778$)536,098$512,777$(1,309$)(344,950$)(393,833$)(355,181$)(290,595$)(260,874$)(211,884$)(226,260$)(195,219$)(80,265$)(286,514$)(260,509$)(221,452$)(76,872$)(10,607$)
Additional Paid-In Capital18,301,472$17,471,675$17,471,675$17,434,486$16,999,280$16,376,479$15,828,748$13,085,715$8,397,109$2,566,484$1,795,125$1,722,724$1,713,669$856,418$1,355,542$312,701$(37,504$)(165,755$)72,412$14,771,741$14,637,720$14,637,720$13,778,848$13,778,848$13,567,948$13,563,598$13,725,598$13,563,598$13,390,318$12,978,068$12,741,706$12,741,706$10,858,206$10,858,206$10,482,515$9,537,515$
Retained Earnings(21,044,246$)(20,522,092$)(20,239,366$)(20,274,803$)(18,921,169$)(18,298,861$)(16,959,641$)(16,297,931$)(15,699,327$)(14,542,779$)(11,226,802$)(6,343,630$)(4,721,923$)(3,912,439$)(3,710,398$)(2,781,800$)(2,241,305$)(1,578,648$)(704,533$)(574,239$)(382,830$)(134,882$)(14,346,520$)(14,230,800$)(86,413$)(14,159,155$)(14,208,038$)(13,947,386$)(13,882,800$)(14,018,079$)(13,804,089$)(13,641,085$)(13,186,044$)(12,834,728$)(13,040,977$)(11,124,972$)(11,085,915$)
Treasury Stock
Capital Lease Obligations